New heart stent under Real-World watch: will it hold up?
NCT ID NCT04899141
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is tracking 400 people with coronary artery disease who received the ihtDEStiny drug-eluting stent during a routine procedure to open blocked heart arteries. Researchers are monitoring how well the stent works over time, including rates of heart attacks, repeat procedures, and deaths. The goal is to see if this stent performs safely in everyday medical practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ihtDEStiny sirolimus-eluting coronary stent
What this could lead to
If successful, this registry could confirm that the ihtDEStiny stent is safe and effective for routine use in opening blocked heart arteries.
What could go wrong
This is an observational registry, not a randomized trial, so it cannot prove the stent is better than other stents. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centro Hospitalar Universitario Do Algarbe
Faro, 8000-386, Portugal
-
Hospital Clinico Universitario Lozano Blesa
Zaragoza, 50009, Spain
-
Hospital Clinico Universitario Santiago de Compostela
Santiago de Compostela, 15706, Spain
-
Hospital Clinico Universitario de Valencia
Valencia, 46010, Spain
-
Hospital General Universitario de Ciudad Real
Ciudad Real, 13005, Spain
-
Hospital General Universitario de Elche
Elche, 03203, Spain
-
Hospital San Pedro de Alcantara
Cáceres, 10003, Spain
-
Hospital Universitari Arnau de Vilanova de Lleida
Lleida, 25198, Spain
-
Hospital Universitari Vall D'Hebron
Barcelona, 08035, Spain
-
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, 08907, Spain
-
Hospital Universitario Donostia
Donostia / San Sebastian, 20014, Spain
-
Hospital Universitario Juan Ramon Jimenez
Huelva, 21005, Spain
-
Hospital Universitario Lucus Agusti
Lugo, 27003, Spain
-
Hospital Universitario Marques de Valdecilla
Santander, 39008, Spain
-
Hospital Universitario Regional de Malaga Carlos Haya
Málaga, Malaga, 29010, Spain
-
Hospital Universitario Virgen Arrixaca
Murcia, 30120, Spain
-
Hospital Universitario Virgen de La Victoria
Málaga, 29010, Spain
-
Hospital Universitario de Araba
Vitoria-Gasteiz, 01009, Spain
-
Hospital Universitario de Cruces
Barakaldo, 48903, Spain
-
Hospital de Galdakao
Galdakao, 48960, Spain